Development of actin dimerization inducers inspired by actin-depolymerizing macrolides
Chemical Communications · 2024
DOI: 10.1039/d4cc01304b ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Communications, 2024. Verfasst von Moeka Itakura und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan. mkita@agr.nagoya-u.ac.jp. Hauptthemen laut MEDLINE: Actins, Macrolides, Protein Multimerization. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Naito Foundation, Astellas Foundation for Research on Metabolic Disorders, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
A side-chain dimer analog of aplyronine A potently depolymerized filamentous actin, and gave a highly distorted and twisted orientation of actin in a 2 : 1 complex.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan. mkita@agr.nagoya-u.ac.jp.
- Bioinformatics Research Center, Indonesian Institute of Bioinformatics, Malang, Jawa Timur 65162, Indonesia.
Förderung
- Naito Foundation
- Astellas Foundation for Research on Metabolic Disorders
- Japan Society for the Promotion of Science
Zitieren
APA
Itakura, M., Utomo, D. H., & Kita, M. (2024). Development of actin dimerization inducers inspired by actin-depolymerizing macrolides. Chemical Communications. https://doi.org/10.1039/d4cc01304b
Vancouver
Itakura M, Utomo DH, Kita M. Development of actin dimerization inducers inspired by actin-depolymerizing macrolides. Chemical Communications. 2024. doi:10.1039/d4cc01304b
BibTeX
@article{Itakura2024,
author = {Itakura, Moeka and Utomo, Didik Huswo and Kita, Masaki},
title = {Development of actin dimerization inducers inspired by actin-depolymerizing macrolides},
journal = {Chemical Communications},
year = {2024},
doi = {10.1039/d4cc01304b}
}
EUVIMED